Monkeypox Concept(BK4583),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BK4583 Monkeypox Concept

Closed 04-08 16:00:00 EDT

1,937.16

+37.34

+1.97%

High1,937.67	Low1,896.88	Vol155.62M
Open1,899.92	D1 Closing1,899.82	Amplitude2.15%
Mkt Cap0.00	Tradable Cap0.00	Total Shares0.00
T/O987.86M	T/O Rate--	Tradable Shares0.00
P/B4.66438	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BK4583","market":"US","secType":"PLATE","nameCN":"Monkeypox Concept","latestPrice":1937.163,"timestamp":1775678399999,"preClose":1899.8214,"halted":0,"volume":155620823,"delay":0,"changeRate":0.019655,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":37.341553,"latestTime":"04-08 16:00:00 EDT","open":1899.9191,"high":1937.666,"low":1896.8827,"amount":987855103.374588,"amplitude":0.021467,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1775692800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":4.66438,"peRate":36.591574,"turnoverRate":0.057651,"increases":8,"decrements":2,"flats":0,"marketCap":214518641223.75,"floatMarketCap":213664613535.0625},"requestUrl":"/m/hq/s/BK4583/wiki","defaultTab":"wiki","newsList":[{"id":"2626922059","title":"Gilead Sciences Inc. Stock Rises Wednesday, Still Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2626922059","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626922059?lang=en_us&edition=fundamental","pubTime":"2026-04-09 04:34","pubTimestamp":1775680440,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  rallied 1.97% to $141.54 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 2.51% to 6,782.81 and the Dow Jones Industrial Average  rising 2.85% to 47,909.92.Gilead Sciences Inc. closed 10.01% below its 52-week high of $157.29, which the company achieved on February 11th.The stock outperformed some of its competitors Wednesday, as Johnson & Johnson  rose 1.21% to $241.30, Pfizer Inc.  rose 1.37% to $27.47, and Abbott Laboratories  rose 1.70% to $103.56.Trading volume  remained 2.2 million below its 50-day average volume of 7.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled April 8, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237957902.USD","LU0203345920.USD","LU1244550221.USD","LU2471134523.USD","SGXZ23171101.USD","LU2602419157.SGD","LU0426417589.USD","LU1280957306.USD","LU0225284248.USD","LU0689626769.HKD","IE000MB6IJN5.SGD","BK4533","IE00B2B36J28.USD","LU1691799644.USD","IE00BJJMRZ35.SGD","LU0426412945.USD","IE00BVYPNV92.GBP","LU0456855351.SGD","IE00B4R5TH58.HKD","LU0345770993.USD","LU2505996681.GBP","LU2750360641.GBP","BK4599","LU1066051811.HKD","LU0122379950.USD","LU0868494617.USD","IE00BKVL7J92.USD","LU2133065610.SGD","IE00BDGV0183.EUR","LU2324357040.USD","LU2347655156.SGD","BK4581","BK4583","LU1778281490.HKD","LU0882574055.USD","LU0861579265.USD","LU2129689514.USD","LU0234572021.USD","IE00BJT1NW94.SGD","LU1162221912.USD","LU0787776722.HKD","IE0002270589.USD","LU0985320562.USD","BK4559","SG9999011175.SGD","LU0124676726.USD","LU0109394709.USD","LU0466842654.USD","BK4504","LU0994945656.USD","LU1059921491.USD","LU1929549753.HKD","BK4592","IE0034235303.USD","LU2471134952.CNY","LU1934455194.USD","LU0306807586.USD","LU1066051225.USD","IE00B3PB1722.GBP","LU0114720955.EUR","LU2129689431.USD","LU0306806265.USD","LU1244550494.USD","LU2430703178.SGD","IE0001KFT4U8.USD","LU1732800096.USD","LU0792757196.USD","BK4007","LU1934455863.HKD","LU1585245621.USD","LU0965509101.SGD","LU0058720904.USD","LU1934455277.USD","LU1066051498.USD","LU1506573853.SGD","LU1037948897.HKD","SGXZ41872573.SGD","LU2430703251.USD","BK4588","IE000WAW04H5.SGD","IE00B19Z3B42.SGD","LU0965508806.USD","LU0985481810.HKD","LU1023059063.AUD","LU2211815571.USD","LU2087621335.USD","LU1244550577.SGD","IE0000B7K699.USD","IE0002141913.USD","SG9999003800.SGD","LU1032955483.USD","LU1914381329.SGD","LU1721429741.USD","LU1732799900.SGD","IE00BLSP4452.SGD","LU0345769128.USD","LU1043141396.HKD","LU1043141123.HKD","IE000BZT7R73.USD","LU1983299246.USD","BK4139","LU1057294990.SGD","LU1989763690.USD","BK4578","LU1267930813.SGD","LU0321505439.SGD","LU1032466523.USD","LU1496350502.SGD","IE00BZ1G4Q59.USD","LU2237957811.SGD","LU2750360997.AUD","BK4550","SG9999013999.USD","LU2592432038.USD","SG9999001176.SGD","IE000M9KFDE8.USD","LU1261432733.SGD","LU0320765992.SGD","SG9999015986.USD","LU0320765646.SGD","LU0795875169.SGD","SG9999015952.SGD","LU0234570918.USD","IE00BVYPNW00.USD","LU1839511570.USD","IE00B7SZLL34.SGD","SG9999002232.USD","LU1894683264.USD","LU0912757837.SGD","BK4568","LU2505996509.AUD","IE00BGHQF631.EUR","IE00B3T34201.USD","LU2430703095.HKD","LU0965509010.AUD","LU1037948541.HKD","LU1196500208.SGD","LU0889566641.SGD","LU1074936037.SGD","IE00B42XCP33.USD","LU1674673428.USD","SG9999001176.USD","SG9999015945.SGD","LU1883839398.USD","LU1571399168.USD","SG9999015978.USD","SGXZ57979304.SGD","BK4566","IE000F7OJYX1.SGD","LU0098860793.USD","LU2471134879.HKD","LU0170899867.USD","IE00BLSP4239.USD","LU2129689605.HKD","LU1989763427.SGD","LU2468319806.SGD","LU1221951046.USD","LU0640476718.USD","LU0965509283.SGD","SG9999002224.SGD","LU0289739699.SGD","LU0345770308.USD","IE00B19Z3581.USD","LU2112291526.USD","LU0889565916.HKD","BK4585","LU0432979614.USD","LU0266013472.USD","SG9999001440.SGD","LU1894683348.USD","LU1121112475.USD","IE00BFTCPJ56.SGD","IE00BSNM7G36.USD","LU1674673691.USD","IE000SO60NU8.SGD","BK4532","LU0321505868.SGD","LU1718418525.SGD","LU0795875086.SGD","LU0345769631.USD","IE0009355771.USD","BK4534","LU0823416689.USD","BK4082","LU0070217475.USD","IE00BFXG1179.USD","LU0683600562.USD","LU1061106388.HKD","LU0225771236.USD","GILD","LU1721429402.USD","LU1066053197.SGD","LU1935042991.SGD","IE00B1BXHZ80.USD","LU1221951129.SGD","IE00BBT3K403.USD","LU1430594728.SGD","LU2471134796.USD","LU0203347892.USD","SG9999004303.SGD","LU2089984988.USD","IE00BN8TJ469.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625281159","title":"Quest Diagnostics Is Maintained at In-Line by Evercore ISI Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2625281159","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625281159?lang=en_us&edition=fundamental","pubTime":"2026-04-08 23:26","pubTimestamp":1775661960,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/DGX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 08, 2026 11:26 ET (15:26 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823417653.USD","LU0823417737.USD","LU0950375773.USD","BK4583","LU2506951875.HKD","LU1854103824.USD","LU2506951958.HKD","DGX","LU1854104046.USD","LU2506952097.USD","BK4196","BK4585","LU2506952170.USD","BK4588","BK4567"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625832928","title":"Gilead Sciences' Tubulis Buy Underscores Shift Beyond HIV, Oppenheimer Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2625832928","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625832928?lang=en_us&edition=fundamental","pubTime":"2026-04-08 23:06","pubTimestamp":1775660786,"startTime":"0","endTime":"0","summary":"Gilead Sciences  agreed to acquire Tubulis for $5 billion, its \"third takeout\" in six weeks as it pushes to diversify beyond its \"core focus on HIV,\" Oppenheimer said in a report Wednesday.The deal follows the recent takeovers of Arcellx  and Ouro, representing a total capital outlay of roughly $15 billion. Analysts at the firm view the latest moves as a strategic effort for \"adding shots on goal\" to Gilead's pipeline, particularly in oncology and autoimmune diseases, the report said, adding that Gilead currently generates about 30% of its revenue outside of infectious diseases.While the \"shopping spree\" highlights a decade-long shift toward cancer and inflammatory treatments, near-term focus for investors is squarely on the launch of Yeztugo, a drug in the company's HIV prevention and treatment lineup, according to the report.Gilead is also supported by high operating margins and a \"dividend yield\" of about 3% to 4%, positioning the company for further growth, Oppenheimer said.Oppenhe","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1430594728.SGD","IE00B3T34201.USD","BK4127","LU1066053197.SGD","LU2112291526.USD","BK4588","ACLX","GILD","IE00BKVL7J92.USD","SG9999015945.SGD","IE00BZ1G4Q59.USD","IE00BSNM7G36.USD","LU0965508806.USD","LU2324357040.USD","IE00B19Z3581.USD","SG9999015986.USD","LU0823416689.USD","BK4578","LU0289739699.SGD","LU0882574055.USD","LU2087621335.USD","BK4566","LU0122379950.USD","LU1839511570.USD","LU1057294990.SGD","LU2468319806.SGD","BK4139","BK4550","LU1571399168.USD","LU1778281490.HKD","LU0234570918.USD","LU1037948541.HKD","LU0320765992.SGD","BK4583","LU1037948897.HKD","SG9999015952.SGD","BK4532","OPY","LU1585245621.USD","LU1934455194.USD","LU0965509101.SGD","BK4585","LU0114720955.EUR","LU1023059063.AUD","LU1674673428.USD","BK4568","LU2089984988.USD","IE00B19Z3B42.SGD","LU0058720904.USD","LU1066051498.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625945267","title":"BUZZ-Truist lifts Gilead PT on expectations of in-line Q1 results","url":"https://stock-news.laohu8.com/highlight/detail?id=2625945267","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625945267?lang=en_us&edition=fundamental","pubTime":"2026-04-08 19:47","pubTimestamp":1775648867,"startTime":"0","endTime":"0","summary":"BUZZ-Truist lifts Gilead PT on expectations of in-line Q1 results** Truist Securities raises PT on drugmaker Gilead Sciences GILD.O to $155 from $152, maintains rating at \"buy\"** New PT represents an 11.7% upside to the stock's last close** Truist expects Q1 results to be broadly in line with Wall Street estimates** Expects revenue of $6.94 bln vs analysts' consensus $6.91 bln and non-GAAP EPS of $1.84 vs consensus of $1.90** Estimates Q1 HIV drug Biktarvy sales of $3.30 bln vs Street expectations of $3.34 bln; sees PrEP drug Yeztugo sales of $167 mln vs expectations of $151 mln     ** Expects Q1 commentary on Yeztugo launch strategy and payer access in the U.S. and EU** To watch out for updates on blood cancer therapy anito-cel launch preparations ahead of December 23 PDUFA date** Anticipates discussion on recent M&A activity, including Ouro and Tubulis, and other near-term growth drivers such as Livdelzi amid evolving liver-disease competition** 26 of 33 brokerages rate the stock \"bu","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260408:nL4N40R10P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1037948897.HKD","LU0965509010.AUD","LU0861579265.USD","LU1571399168.USD","LU0823416689.USD","IE00BZ1G4Q59.USD","LU0320765992.SGD","LU1934455277.USD","BK4588","LU1037948541.HKD","IE00B7SZLL34.SGD","LU0109394709.USD","GILD","IE00BSNM7G36.USD","LU0114720955.EUR","LU0889565916.HKD","IE00B19Z3581.USD","LU1066051498.USD","LU2112291526.USD","LU0882574055.USD","SG9999015978.USD","BK4568","IE00B3T34201.USD","IE00BKVL7J92.USD","BK4583","LU1057294990.SGD","BK4578","LU1934455194.USD","LU1674673428.USD","BK4139","BK4550","LU1023059063.AUD","BK4585","LU2324357040.USD","LU0234570918.USD","IE00B19Z3B42.SGD","LU0058720904.USD","SG9999015986.USD","LU0122379950.USD","BK4532","LU1778281490.HKD","LU2468319806.SGD","LU2089984988.USD","LU1430594728.SGD","LU1839511570.USD","BK4566","LU0965508806.USD","SG9999015952.SGD","LU1934455863.HKD","LU1066053197.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625917774","title":"Nurix Therapeutics Q1 loss widens on higher costs","url":"https://stock-news.laohu8.com/highlight/detail?id=2625917774","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625917774?lang=en_us&edition=fundamental","pubTime":"2026-04-08 18:09","pubTimestamp":1775642986,"startTime":"0","endTime":"0","summary":"Nurix Therapeutics Q1 loss widens on higher costsOverviewUS biopharmaceutical firm's fiscal Q1 revenue fell sharply yr/yr as collaboration revenue declinedOperating expenses for fiscal Q1 rose, driven","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260408:nL1N40R0CG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","SG9999015978.USD","IE00B3T34201.USD","LU0225284248.USD","SG9999015945.SGD","IE0002270589.USD","BK4583","LU0868494617.USD","IE00BLSP4452.SGD","BK4534","SG9999015986.USD","LU1839511570.USD","LU0823416689.USD","LU1037948541.HKD","LU0114720955.EUR","LU1061106388.HKD","LU1585245621.USD","LU0234570918.USD","IE00B7SZLL34.SGD","LU0965509101.SGD","LU0109394709.USD","LU0170899867.USD","BK4007","LU1934455277.USD","IE00BLSP4239.USD","IE000M9KFDE8.USD","NRIX","LU0225771236.USD","LU2089984988.USD","IE00BBT3K403.USD","SG9999011175.SGD","SG9999002224.SGD","BK4578","SG9999001176.SGD","LU2468319806.SGD","BK4592","LU2112291526.USD","LU1894683264.USD","IE00B19Z3581.USD","SG9999002232.USD","BK4550","SG9999001176.USD","BK4568","SGXZ57979304.SGD","LU1778281490.HKD","LU0965508806.USD","LU0985481810.HKD","BK4585","LU1674673691.USD","LU1934455194.USD","LU1934455863.HKD","BK4588","LU1066053197.SGD","IE00BKVL7J92.USD","LU1037948897.HKD","SG9999013999.USD","LU0306807586.USD","LU0320765992.SGD","LU0122379950.USD","BK4599","IE00BZ1G4Q59.USD","LU0965509010.AUD","LU2087621335.USD","LU1066051498.USD","SG9999015952.SGD","BK4533","LU0306806265.USD","LU0882574055.USD","BK4139","LU0861579265.USD","LU0321505439.SGD","LU0321505868.SGD","LU1057294990.SGD","IE00BSNM7G36.USD","LU1023059063.AUD","BK4581","LU0058720904.USD","LU2324357040.USD","IE00B19Z3B42.SGD","SG9999003800.SGD","LU0456855351.SGD","LU1674673428.USD","LU0889565916.HKD","LU1430594728.SGD","LU1894683348.USD","LU0234572021.USD","LU1571399168.USD","LU0289739699.SGD","LU0965509283.SGD","LU1883839398.USD","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625917924","title":"Gilead’s Tubulis Acquisition: Building an ADC Oncology Franchise and Enhancing Risk‑Reward for GILD Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2625917924","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625917924?lang=en_us&edition=fundamental","pubTime":"2026-04-08 17:45","pubTimestamp":1775641543,"startTime":"0","endTime":"0","summary":"In a report released today, Joseph Stringer from Needham maintained a Buy rating on Gilead Sciences, with a price target of $170.00. Joseph Stringe...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/gileads-tubulis-acquisition-building-an-adc-oncology-franchise-and-enhancing-risk‑reward-for-gild-shares-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/gileads-tubulis-acquisition-building-an-adc-oncology-franchise-and-enhancing-risk‑reward-for-gild-shares-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0289739699.SGD","LU0114720955.EUR","LU1674673428.USD","LU2112291526.USD","ADC","IE00B3T34201.USD","LU1037948897.HKD","LU1037948541.HKD","LU1778281490.HKD","SG9999015945.SGD","LU0882574055.USD","IE0002270589.USD","SG9999015986.USD","LU0889565916.HKD","LU2324357040.USD","LU0109394709.USD","LU0234570918.USD","BK4080","IE00B19Z3581.USD","BK4578","BK4583","LU0965509283.SGD","LU1585245621.USD","LU1057294990.SGD","BK4139","SG9999015978.USD","LU1066053197.SGD","BK4231","IE00B7SZLL34.SGD","SG9999015952.SGD","LU0122379950.USD","BK4568","LU1061106388.HKD","BK4585","LU0320765992.SGD","LU1023059063.AUD","GILD","IE00B19Z3B42.SGD","IE00BKVL7J92.USD","LU0058720904.USD","LU1430594728.SGD","LU1571399168.USD","LU2087621335.USD","LU0965509101.SGD","LU1839511570.USD","LU0823416689.USD","LU0965509010.AUD","LU1674673691.USD","LU1934455277.USD","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625253965","title":"Inovio announces annual shareholder meeting in virtual-only format","url":"https://stock-news.laohu8.com/highlight/detail?id=2625253965","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625253965?lang=en_us&edition=fundamental","pubTime":"2026-04-08 04:13","pubTimestamp":1775592816,"startTime":"0","endTime":"0","summary":"Inovio Pharmaceuticals schedules virtual annual stockholder meeting for May 20, 2026.Ballot includes election of eight directors for terms running to 2027.Agenda also includes advisory vote on executive compensation.Meeting will also consider amendment and restatement of 2023 omnibus incentive plan, including 8,000,000 additional shares for issuance.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Inovio Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 07, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nNDL8fGsPt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","INO","BK4139","BK4583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625968717","title":"Tonix publishes investor deck highlighting TONMYA fibromyalgia launch, reports USD 208 million cash","url":"https://stock-news.laohu8.com/highlight/detail?id=2625968717","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625968717?lang=en_us&edition=fundamental","pubTime":"2026-04-08 02:48","pubTimestamp":1775587724,"startTime":"0","endTime":"0","summary":"Tonix highlighted commercial rollout of fibromyalgia drug TONMYA, reporting USD 1.4 million in net sales for period Nov. 17-Dec. 31, 2025.Through Feb. 27, 2026, more than 1,500 prescribers wrote TONMYA prescriptions; about 2,500 patients started treatment.Cumulative prescriptions reached about 4,200, including bridge prescriptions.Deck outlined cash position of about USD 208 million as of Dec. 31, 2025; company reported no debt.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tonix Pharmaceuticals Holding Corp. published the original content used to generate this news brief on April 07, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nNDL5K6mDq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","TNXP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625950939","title":"Leerink says Tubulis deal highlights value of ADC platforms like Sutro’s","url":"https://stock-news.laohu8.com/highlight/detail?id=2625950939","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625950939?lang=en_us&edition=fundamental","pubTime":"2026-04-08 01:30","pubTimestamp":1775583048,"startTime":"0","endTime":"0","summary":"Leerink analyst Andrew Berens notes Gilead (GILD) announced plans to acquire Tubulis for $3.15B in cash plus up to $1.85B in contingent milestone p...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/leerink-says-tubulis-deal-highlights-value-of-adc-platforms-like-sutros-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/leerink-says-tubulis-deal-highlights-value-of-adc-platforms-like-sutros-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1778281490.HKD","LU1571399168.USD","LU0882574055.USD","LU0289739699.SGD","BK4231","LU0320765992.SGD","LU0965509010.AUD","LU1934455277.USD","LU1934455863.HKD","SG9999015945.SGD","LU2112291526.USD","LU1057294990.SGD","LU0965509101.SGD","LU1061106388.HKD","LU0234570918.USD","LU1037948541.HKD","BK4588","LU1430594728.SGD","LU1023059063.AUD","LU1839511570.USD","LU0861579265.USD","LU0109394709.USD","IE00B19Z3B42.SGD","BK4532","LU0122379950.USD","LU1934455194.USD","BK4080","IE00BKVL7J92.USD","ADC","LU2468319806.SGD","BK4578","BK4568","BK4585","BK4583","LU0114720955.EUR","SG9999015986.USD","IE00B19Z3581.USD","GILD","LU2089984988.USD","LU1066051498.USD","BK4550","LU0965508806.USD","LU2087621335.USD","LU0889565916.HKD","LU2324357040.USD","BK4139","IE00B3T34201.USD","IE00BZ1G4Q59.USD","IE00B7SZLL34.SGD","LU0965509283.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625574809","title":"Sector Update: Health Care","url":"https://stock-news.laohu8.com/highlight/detail?id=2625574809","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625574809?lang=en_us&edition=fundamental","pubTime":"2026-04-08 01:03","pubTimestamp":1775581406,"startTime":"0","endTime":"0","summary":"Health care stocks declined Tuesday afternoon, with the NYSE Health Care Index and the State Street Health Care Select Sector SPDR ETF  each fractionally lower.The iShares Biotechnology ETF  shed 0.9%.In corporate news, Gilead Sciences  has agreed to acquire Germany-based Tubulis for up to $5 billion, aiming to expand its oncology pipeline. Gilead shares were down 1.2%.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0289739699.SGD","LU0114720955.EUR","LU1674673428.USD","LU2112291526.USD","IE00B3T34201.USD","LU1037948897.HKD","LU1778281490.HKD","BK4550","BK4581","LU0861579265.USD","SG9999015945.SGD","LU1934455863.HKD","LU0965508806.USD","LU0882574055.USD","IE0002270589.USD","SG9999015986.USD","XLV","LU2324357040.USD","BK4566","LU0109394709.USD","BK4532","BK4588","BK4578","IE00BSNM7G36.USD","BK4583","LU0965509283.SGD","LU1585245621.USD","IBB","SG9999015978.USD","LU1066053197.SGD","LABU","IE00B7SZLL34.SGD","BK4568","LU1061106388.HKD","LU0320765992.SGD","LU1023059063.AUD","GILD","IE00BKVL7J92.USD","LU1430594728.SGD","LU2087621335.USD","LU1571399168.USD","XBI","LU0965509101.SGD","LU1066051498.USD","LU1839511570.USD","LU0823416689.USD","LU0965509010.AUD","LU1674673691.USD","LU2468319806.SGD","LU1037948541.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625951809","title":"Gilead to acquire Tubulis for $3.15B upfront, up to $1.85B in milestone payments","url":"https://stock-news.laohu8.com/highlight/detail?id=2625951809","media":"TIPRANKS","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625951809?lang=en_us&edition=fundamental","pubTime":"2026-04-07 22:31","pubTimestamp":1775572273,"startTime":"0","endTime":"0","summary":"Gilead (GILD) Sciences entered into a definitive agreement to acquire Tubulis, a private Germany-based, clinical-stage biotechnology company develo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gilead-to-acquire-tubulis-for-3-15b-upfront-up-to-1-85b-in-milestone-payments-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gilead-to-acquire-tubulis-for-3-15b-upfront-up-to-1-85b-in-milestone-payments-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1674673428.USD","LU1674673691.USD","BK4588","LU0965509283.SGD","LU0289739699.SGD","IE00B19Z3581.USD","LU1585245621.USD","LU0965508806.USD","SG9999015945.SGD","BK4585","LU0965509101.SGD","SG9999015952.SGD","LU1066051498.USD","BK4532","LU1934455863.HKD","BK4568","LU0823416689.USD","LU1057294990.SGD","LU0320765992.SGD","LU1037948541.HKD","LU1839511570.USD","SG9999015986.USD","LU0122379950.USD","LU0965509010.AUD","LU1934455194.USD","GILD","LU1023059063.AUD","IE0002270589.USD","BK4566","BK4578","LU1430594728.SGD","LU2089984988.USD","SG9999015978.USD","IE00B3T34201.USD","LU0109394709.USD","LU2324357040.USD","LU1061106388.HKD","BK4583","LU1934455277.USD","LU0889565916.HKD","BK4139","LU1571399168.USD","IE00BKVL7J92.USD","IE00B19Z3B42.SGD","LU1066053197.SGD","LU0882574055.USD","LU1037948897.HKD","LU0861579265.USD","LU2112291526.USD","BK4550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625295919","title":"Gilead Buying Another Cancer-Drug Partner -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2625295919","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625295919?lang=en_us&edition=fundamental","pubTime":"2026-04-07 22:23","pubTimestamp":1775571780,"startTime":"0","endTime":"0","summary":"1023 ET - Gilead Sciences is buying out another cancer-drug partner with its deal to pay up to $5 billion for Tubulis. Gilead in February said it would buy the rest of Arcellx, its partner in developing a potential CAR T-cell therapy for the blood cancer multiple myeloma, in a deal valuing the biotech company at about $7.8 billion at closing. Analysts at RBC Capital Markets say the Tubulis acquisition represents a strategically sound bolt-on that addresses Gilead's oncology pipeline growth needs while securing differentiated next-generation antibody-drug conjugate platform capabilities. ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739699.SGD","LU1674673428.USD","ACLX","LU1037948897.HKD","LU1037948541.HKD","BK4550","LU0861579265.USD","SG9999015945.SGD","LU1934455863.HKD","LU1934455194.USD","LU0965508806.USD","LU0882574055.USD","IE0002270589.USD","SG9999015986.USD","LU0889565916.HKD","BK4566","LU0109394709.USD","LU0234570918.USD","BK4532","BK4588","IE00B19Z3581.USD","BK4578","IE00BSNM7G36.USD","BK4583","LU0965509283.SGD","LU1585245621.USD","LU1057294990.SGD","BK4139","SG9999015978.USD","LU2089984988.USD","IE00B7SZLL34.SGD","LU0122379950.USD","BK4568","LU1061106388.HKD","BK4585","LU1023059063.AUD","GILD","IE00BKVL7J92.USD","LU1430594728.SGD","LU0058720904.USD","LU2087621335.USD","LU1571399168.USD","LU0965509101.SGD","LU1066051498.USD","LU1839511570.USD","LU0823416689.USD","LU0965509010.AUD","LU1674673691.USD","LU1934455277.USD","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192601518","title":"Gilead Sciences Invests $5 Billion in ADC Sector with Acquisition of Germany's Tubulis","url":"https://stock-news.laohu8.com/highlight/detail?id=1192601518","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192601518?lang=en_us&edition=fundamental","pubTime":"2026-04-07 21:17","pubTimestamp":1775567842,"startTime":"0","endTime":"0","summary":"Gilead Sciences has agreed to acquire the German private biotechnology firm Tubulis GmbH in a deal valued at up to $5 billion. The move is intended to strengthen its portfolio in the emerging and...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","LU1674673691.USD","LU2087621335.USD","BK4080","LU1674673428.USD","LU0234570918.USD","IE00BKVL7J92.USD","LU1571399168.USD","LU0965508806.USD","LU1839511570.USD","FDAXmain","SG9999015986.USD","LU1057294990.SGD","BK4568","BK4532","LU0114720955.EUR","BK4588","LU0889565916.HKD","LU1934455863.HKD","ADC","LU0861579265.USD","LU0965509101.SGD","SG9999015945.SGD","LU0109394709.USD","IE00B19Z3581.USD","GILD","IE00B3T34201.USD","LU1066051498.USD","FDXSmain","LU0965509010.AUD","IE00B19Z3B42.SGD","LU0823416689.USD","IE00B7SZLL34.SGD","IE00BZ1G4Q59.USD","LU2112291526.USD","LU2324357040.USD","BK4550","LU0122379950.USD","LU1778281490.HKD","LU1934455277.USD","SG9999015978.USD","LU1061106388.HKD","LU1023059063.AUD","LU1066053197.SGD","LU2468319806.SGD","IE0002270589.USD","BK4231","LU0058720904.USD","BK4578","LU0320765992.SGD","LU1430594728.SGD","LU1934455194.USD","BK4139","SG9999015952.SGD","LU0289739699.SGD","BK4583","LU0882574055.USD","LU2089984988.USD","LU0965509283.SGD","IE00BSNM7G36.USD","BK4585","LU1037948541.HKD","FDXMmain","LU1037948897.HKD","LU1585245621.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625955028","title":"What's Going On With Inovio Pharmaceuticals Stock On Tuesday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2625955028","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625955028?lang=en_us&edition=fundamental","pubTime":"2026-04-07 21:15","pubTimestamp":1775567700,"startTime":"0","endTime":"0","summary":"Inovio prices a $17.5 million share offering, narrows losses, cuts expenses, and advances INO-3107 under FDA review.","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/04/07/Genetic-Research-And-Biotech-Science-Con.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/04/07/Genetic-Research-And-Biotech-Science-Con.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/health-care/26/04/51678783/whats-going-on-with-inovio-pharmaceuticals-stock-on-tuesday","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/26/04/51678783/whats-going-on-with-inovio-pharmaceuticals-stock-on-tuesday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4139","BK4583","INO","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625958987","title":"Gilead to Acquire Tubulis Adding Potentially Best-in-Class Antibody-Drug Conjugate and Next Generation Platform to Further Strengthen Oncology Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2625958987","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625958987?lang=en_us&edition=fundamental","pubTime":"2026-04-07 20:30","pubTimestamp":1775565000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nTUA5D5LQP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BSNM7G36.USD","LU0234570918.USD","LU1037948897.HKD","LU2112291526.USD","GILD","SG9999015952.SGD","LU0122379950.USD","BK4585","LU2087621335.USD","LU1023059063.AUD","BK4566","LU0289739699.SGD","LU0109394709.USD","LU1839511570.USD","LU0861579265.USD","LU1934455194.USD","BK4532","IE00B19Z3581.USD","IE00B19Z3B42.SGD","LU1061106388.HKD","LU1934455863.HKD","LU1066051498.USD","LU1430594728.SGD","LU1778281490.HKD","LU1934455277.USD","LU0965508806.USD","LU0320765992.SGD","LU0965509283.SGD","LU1066053197.SGD","BK4550","LU0889565916.HKD","LU0058720904.USD","LU2089984988.USD","BK4583","LU1571399168.USD","LU1674673691.USD","LU1057294990.SGD","BK4588","LU0882574055.USD","LU1037948541.HKD","LU1674673428.USD","IE00B3T34201.USD","IE00B7SZLL34.SGD","IE0002270589.USD","LU0965509101.SGD","SG9999015978.USD","LU0114720955.EUR","IE00BZ1G4Q59.USD","LU2324357040.USD","SG9999015986.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625087930","title":"BRIEF-Gilead Sciences To Acquire Tubulis GmbH","url":"https://stock-news.laohu8.com/highlight/detail?id=2625087930","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625087930?lang=en_us&edition=fundamental","pubTime":"2026-04-07 20:15","pubTimestamp":1775564148,"startTime":"0","endTime":"0","summary":"BRIEF-Gilead Sciences To Acquire Tubulis GmbHApril 7  - Gilead Sciences Inc GILD.O:GILEAD SCIENCES: TO ACQUIRE TUBULIS GMBHGILEAD SCIENCES: WILL ACQUIRE ALL OF OUTSTANDING EQUITY OF TUBULIS FOR $3.15 BILLION IN UPFRONT CASH CONSIDERATION ON CASH-FREE, DEBT-FREE BASISGILEAD SCIENCES: DEAL INCLUDES UP TO $1.85 BILLION IN CONTINGENT MILESTONE PAYMENTSGILEAD SCIENCES: PLANS TO FINANCE DEAL WITH COMBINATION OF CASH ON HAND & SENIOR UNSECURED NOTESSource text: [ID:]Further company coverage: GILD.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nP8N3W407W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3B42.SGD","LU0965509101.SGD","LU1037948897.HKD","LU1674673691.USD","LU0320765992.SGD","LU0965508806.USD","LU1934455194.USD","IE00BSNM7G36.USD","SG9999015952.SGD","LU0889565916.HKD","LU1934455863.HKD","GILD","LU2087621335.USD","LU1061106388.HKD","SG9999015945.SGD","BK4139","LU2089984988.USD","BK4585","LU0289739699.SGD","BK4588","LU2112291526.USD","LU1057294990.SGD","BK4566","LU0965509010.AUD","IE0002270589.USD","LU0122379950.USD","BK4578","LU0861579265.USD","SG9999015986.USD","LU0234570918.USD","LU1430594728.SGD","LU1585245621.USD","LU1934455277.USD","LU2324357040.USD","LU2468319806.SGD","IE00BKVL7J92.USD","LU1066051498.USD","BK4550","LU0823416689.USD","BK4568","LU0965509283.SGD","BK4532","LU1066053197.SGD","LU1571399168.USD","IE00BZ1G4Q59.USD","LU0109394709.USD","LU1023059063.AUD","IE00B7SZLL34.SGD","BK4583","IE00B19Z3581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625930792","title":"Gilead Sciences: to Acquire Tubulis Gmbh","url":"https://stock-news.laohu8.com/highlight/detail?id=2625930792","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625930792?lang=en_us&edition=fundamental","pubTime":"2026-04-07 20:15","pubTimestamp":1775564144,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nP8N3W407W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GILD","LU1023059063.AUD","LU2324357040.USD","LU0320765992.SGD","IE0002270589.USD","BK4550","LU1066053197.SGD","LU0122379950.USD","LU2087621335.USD","IE00BKVL7J92.USD","LU0234570918.USD","BK4588","LU0889565916.HKD","LU1674673691.USD","BK4585","LU0965509283.SGD","SG9999015978.USD","LU1061106388.HKD","BK4568","LU1037948541.HKD","SG9999015952.SGD","BK4566","LU1839511570.USD","SG9999015945.SGD","LU0861579265.USD","LU0289739699.SGD","IE00B3T34201.USD","LU0109394709.USD","IE00BZ1G4Q59.USD","LU1057294990.SGD","LU0058720904.USD","LU0965508806.USD","LU0882574055.USD","SG9999015986.USD","LU0965509101.SGD","BK4583","LU1571399168.USD","BK4532","LU0965509010.AUD","LU2089984988.USD","LU1934455194.USD","LU1037948897.HKD","LU1066051498.USD","LU2112291526.USD","IE00B19Z3581.USD","LU0114720955.EUR","LU1934455277.USD","LU0823416689.USD","IE00BSNM7G36.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625930781","title":"Gilead Sciences: Deal Includes up to $1.85 Bln in Contingent Milestone Payments","url":"https://stock-news.laohu8.com/highlight/detail?id=2625930781","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625930781?lang=en_us&edition=fundamental","pubTime":"2026-04-07 20:15","pubTimestamp":1775564144,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nP8N3W407W:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","IE00BKVL7J92.USD","LU0965509010.AUD","LU2112291526.USD","BK4566","LU0889565916.HKD","LU1674673691.USD","LU0965509101.SGD","BK4578","SG9999015986.USD","LU1934455277.USD","SG9999015945.SGD","LU2087621335.USD","IE00B19Z3B42.SGD","IE00BSNM7G36.USD","LU0320765992.SGD","LU1066051498.USD","LU1934455863.HKD","LU1934455194.USD","LU2468319806.SGD","BK4583","LU0122379950.USD","IE00B19Z3581.USD","IE00BZ1G4Q59.USD","BK4550","BK4532","LU0289739699.SGD","BK4568","IE0002270589.USD","LU0965508806.USD","IE00B7SZLL34.SGD","LU0965509283.SGD","LU0823416689.USD","LU0861579265.USD","LU1037948897.HKD","LU1066053197.SGD","LU2089984988.USD","GILD","LU0234570918.USD","LU1430594728.SGD","LU1585245621.USD","SG9999015952.SGD","BK4139","LU1057294990.SGD","LU1061106388.HKD","LU1571399168.USD","LU1023059063.AUD","BK4588","LU2324357040.USD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625780930","title":"Gilead Sciences: Will Acquire All of Outstanding Equity of Tubulis for $3.15 Bln in Upfront Cash Consideration on Cash-Free, Debt-Free Basis","url":"https://stock-news.laohu8.com/highlight/detail?id=2625780930","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625780930?lang=en_us&edition=fundamental","pubTime":"2026-04-07 20:15","pubTimestamp":1775564144,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nP8N3W407W:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0965509283.SGD","LU2087621335.USD","LU1674673428.USD","SG9999015952.SGD","IE00BSNM7G36.USD","LU1066053197.SGD","BK4566","LU0861579265.USD","BK4585","LU0289739699.SGD","BK4568","IE00BKVL7J92.USD","LU2468319806.SGD","SG9999015978.USD","IE00B7SZLL34.SGD","IE00B19Z3B42.SGD","LU0114720955.EUR","LU0965508806.USD","IE00BZ1G4Q59.USD","BK4583","LU1934455277.USD","LU0122379950.USD","LU1934455194.USD","LU1037948541.HKD","BK4578","LU0320765992.SGD","BK4139","LU0234570918.USD","LU1571399168.USD","SG9999015986.USD","LU1839511570.USD","LU2324357040.USD","LU0058720904.USD","BK4588","LU0965509010.AUD","LU0882574055.USD","LU1023059063.AUD","LU1057294990.SGD","IE00B3T34201.USD","GILD","IE00B19Z3581.USD","BK4532","LU0823416689.USD","LU1934455863.HKD","IE0002270589.USD","LU1585245621.USD","LU0109394709.USD","LU1778281490.HKD","LU0889565916.HKD","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625307969","title":"Gilead Sciences: Plans to Finance Deal With Combination of Cash on Hand & Senior Unsecured Notes","url":"https://stock-news.laohu8.com/highlight/detail?id=2625307969","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625307969?lang=en_us&edition=fundamental","pubTime":"2026-04-07 20:15","pubTimestamp":1775564144,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nP8N3W407W:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IE00B7SZLL34.SGD","IE00BKVL7J92.USD","SG9999015952.SGD","LU0289739699.SGD","LU2089984988.USD","LU1430594728.SGD","LU1037948897.HKD","LU1037948541.HKD","LU0109394709.USD","LU1066053197.SGD","BK4568","LU1934455863.HKD","LU1023059063.AUD","LU2324357040.USD","BK4583","IE00BZ1G4Q59.USD","LU1571399168.USD","LU0320765992.SGD","IE00B19Z3581.USD","LU1061106388.HKD","IE0002270589.USD","LU0882574055.USD","IE00B19Z3B42.SGD","LU1839511570.USD","LU1585245621.USD","GILD","LU2468319806.SGD","LU1674673428.USD","LU2112291526.USD","SG9999015978.USD","LU0861579265.USD","LU0234570918.USD","SG9999015945.SGD","BK4532","BK4585","LU0965508806.USD","LU1934455194.USD","LU0122379950.USD","LU0114720955.EUR","LU0058720904.USD","LU1934455277.USD","LU0823416689.USD","LU1066051498.USD","LU0889565916.HKD","LU1057294990.SGD","BK4578","LU0965509101.SGD","SG9999015986.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":0.0137},{"period":"1month","weight":-0.0196},{"period":"3month","weight":-0.044},{"period":"6month","weight":-0.0178},{"period":"1year","weight":0.307},{"period":"ytd","weight":-0.0333}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"name":"BK4583","nameEN":"BK4583"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Monkeypox Concept(BK4583),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Monkeypox Concept(BK4583) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Monkeypox Concept,BK4583,Monkeypox Concept股票,Monkeypox Concept股票老虎,Monkeypox Concept股票老虎国际,Monkeypox Concept行情,Monkeypox Concept股票行情,Monkeypox Concept股价,Monkeypox Concept股市,Monkeypox Concept股票价格,Monkeypox Concept股票交易,Monkeypox Concept股票购买,Monkeypox Concept股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Monkeypox Concept(BK4583),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Monkeypox Concept(BK4583) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction